Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: ‘COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs’ by Conticini et al
Open Access
- 15 May 2020
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 80 (2), e15
- https://doi.org/10.1136/annrheumdis-2020-217738
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugsAnnals Of The Rheumatic Diseases, 2020
- COVID-19 and rheumatology: first steps towards a different future?Annals Of The Rheumatic Diseases, 2020
- Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapiesAnnals Of The Rheumatic Diseases, 2020